Normative substantiation of production, quality control and safety of medicinal products on the basis of nanomaterials

Authors

DOI:

https://doi.org/10.15587/2519-4852.2017.109071

Keywords:

nanomaterials, nanotechnologies, medicinal preparations, normative documents, quality control, safety, standards

Abstract

Aim. The analysis of Ukrainian normative documents concerning remedies based on nanomaterials and the study of international experience on their development, quality control and safety.

Methods. Methods of information retrieval and literature data analysis have been used.

Results. The analysis of the State Pharmacopoeia of Ukraine, the orders of the Ministry of Health of Ukraine and other Ukrainian normative documents concerning medicines based on nanomaterials, as well as the EU legal framework on nanotechnologies and nanomaterials has been conducted. The necessity of development and approval in Ukraine of the regulatory and legal framework for medicines based on nanomaterials has been substantiated.

Conclusion. The question of expediency of working out the normative and legal base for creation of medicines on the basis of nanomaterials in Ukraine is uncontested. The first steps in this direction have already been taken, but the question is still far from the solution. The lack of regulatory requirements for production, quality control and safety of medicines with nanomaterials complicates their development and makes it impossible to introduce into production

Author Biographies

Svіtlana Bilous, Danylo Halytsky Lviv National Medical University Pekarska str., 69, Lviv, Ukraine, 79010

PhD, Associate Professor

Department of Drug Technology and Biopharmaceutics

Timofiy Kalyniuk, Danylo Halytsky Lviv National Medical University Pekarska str., 69, Lviv, Ukraine, 79010

Doctor of Pharmaceutical Sciences, Professor

Department of Drug Technology and Biopharmaceutics

References

  1. Ulberg, Z. R., Gruzina, T. G, Dybkova, S. M. et. al. (2010). Biobezpechni nanochastinki metaliv v nanomedicine ta nanobiotekhnologii. Visnyk problem biologii ta medicini, 4, 72–77.
  2. Ulberg, Z., Gruzina, T., Karpov, O. (2008). Nanotekhnologiia v medicine: rol koloidno-khimichnikh procesiv. Visnyk NANU, 8, 28–41.
  3. Regulation (EC) No 1223/2009 of the European Parliament and of the Council of 30 November 2009 on cosmetic products. Available at: http://eur-lex.europa.eu/legal-content/EN/ALL/?uri=CELEX%3A32009R1223
  4. Regulation (EC) No 1333/2008 of the European Parliament and of the Council of 16 December 2008 on food additives. Available at: http://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32008R1333
  5. Regulation (EU) No 1169/2011 of the European Parliament and of the Council of 25 October 2011 on the provision of food information to consumers. Available at: http://eur-lex.europa.eu/legal-content/EN/ALL/?uri=CELEX%3A32011R1169
  6. International Organization for Standardization. ІSO/TC 229 Nanotechnologies. Available at: https://www.iso.org/committee/381983.html
  7. Pavlyho, T. M., Serdyuk, H. H., Shevchenko, V. Y. (2010). Standartyzatsyya v oblasty nanotekhnolohyi y nanomateryalov. Nanostrukturnoe materyalovedenye, 3, 70–80.
  8. Piminov, A. F. (2014). Nanotekhnolohii v farmatsii i medytsyne. Vol. 1. Vol. 2. Kharkiv: Fakt, 672, 820.
  9. Farmatsevtychna entsyklopediya. Available at: www.pharmencyclopedia.com.ua
  10. Derzhavna Farmakopeia Ukrainy. Vol. 1. Vol. 2. Vol. 3 (2015). Kharkiv: Derzhavne pidpryiemstvo «Ukrainskyi naukovyi farmakopeinyi tsentr yakosti likarskykh zasobiv», 1128, 724, 732.
  11. Borshchevs'kyi, H. I. (2016). Teoretychne obgruntuvannya ta rozrobka liposomal'nykh likars'kykh preparativ u formi inektsiynoho rozchynu ta spreyu na osnovi nanobiotekhnolohiyi. Kharkiv, 41.
  12. European Medicines Agency. Available at: http://www.ema.europa.eu/ema/index.jsp?curl=pages/home/Home_Page.jsp&mid
  13. Directive 2001/83/EC of the Europian parliament and of the counsil of 6 November 2001 on the Community code relating to medicinal products for human use (2012). 188. Available at: http://ec.europa.eu/health//sites/health/files/files/eudralex/vol-1/dir_2001_83_consol_2012/dir_2001_83_cons_2012_en.pdf
  14. Regulation (EC) No 1394/2007 of the Europian parliament and of the counsil of 13 November 2007 on advanced therapy medicinal products and amending Directive 2001/83/EC and Regulation (EC) No 726/2004. Available at: http://ec.europa.eu/health/sites/health/files/files/eudralex/vol-1/reg_2007_1394/reg_2007_1394_en.pdf
  15. Pro zatverdzhennya Poryadku provedennya ekspertyzy reyestratsiynykh materialiv na likars'ki zasoby, shcho podayut'sya na derzhavnu reyestratsiyu (perereyestratsiyu), a takozh ekspertyzy materialiv pro vnesennya zmin do reyestratsiynykh materialiv protyahom diyi reyestratsiynoho posvidchennya (2005). MOZ Ukrayiny, No. 426. Available at: http://zakon4.rada.gov.ua/laws/show/z1069-05
  16. Regulation (EC) No 1907/2006 of the European Parliament and of the Council of 18 December 2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH). Available at: http://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX%3A02006R1907-20140410
  17. Marchenko, M. L. (2011). Kul'tura klityn lyudyny yak al'ternatyvnyi metod v kompleksniy toksykoloho-hihiyenichniy otsintsi spoluk vazhkykh metaliv. Kyiv, 22.
  18. Otsinka bezpeky likars'kykh nanopreparativ (2013). Kyiv, 108.
  19. Trakhtenberh, I. M., Ulberh, Z. R., Chekman I. S. (2014). Obhruntuvannya dotsil'nosti stvorennya i vprovadzhennya normatyvno-metodychnoyi bazy otsinky bezpeky likars'kykh nanopreparativ v Ukrayini. Naukovyi zhurnal MOZ Ukrayiny, 2 (6), 20–26.
  20. Antypova, O. E. (2006). Farmatsevtycheskaya razrabotka – zaloh kachestva lekarstvennikh sredstv. Visnyk farmakolohiyi ta farmatsiyi, 8, 72–80.
  21. Bezuhla, E. P., Lyapunov, N. A., Bovtenko, V. A. (2008). Metodolohycheskyi pokhod k farmatsevtycheskoy razrabotke lekarstvennikh preparatov y eho standartyzatsyia. Promishlennoe obozrenye, 6 (11), 36–41.
  22. Swarbick, J. (Ed.) (2007). Encyclopedia of pharmaceutical technology. Third Edition. New York-London: Informa healthcare, 1171.
  23. Nastanova 42-3.1:2004. Nastanovy z yakosti. Likars'ki zasoby. Farmacevtichna rozrobka (2004). Kyiv: MOZ Ukrainy, 15.
  24. Nastanova 42-3.0:2011. Likars'ki zasoby. Farmatsevtychna rozrobka (ICH Q8) (2011). Kyiv: MOZ Ukrayiny, 33.
  25. Bilous, S. B., Kalynyuk, T. H., Chekman, I. S. (2012). Zahalni pidkhody do farmatsevtychnoyi rozrobky ta do klinichnykh doslidzhen likarskykh zasobiv z nanorozmirnymy aktyvnymy farmatsevtychnymy inhrediyentamy. Klinichna farmatsiya, farmakoterapiya ta medychna standartyzatsiya, 3 (16), 67–73.

Downloads

Published

2017-08-31

How to Cite

Bilous, S., & Kalyniuk, T. (2017). Normative substantiation of production, quality control and safety of medicinal products on the basis of nanomaterials. ScienceRise: Pharmaceutical Science, (4 (8), 36–40. https://doi.org/10.15587/2519-4852.2017.109071

Issue

No. 4 (8) (2017)

Section

Pharmaceutical Science

License

Copyright (c) 2017 Svіtlana Bilous, Timofiy Kalyniuk

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Our journal abides by the Creative Commons CC BY copyright rights and permissions for open access journals.